A series of progress and achievements in liver cancer were released, and Bayer helped China to develop high-quality development of cancer prevention and treatment

Treatments for liver cancer include surgical resection, targeted therapy and immunotherapy, and progress has been made thanks to the innovative achievements of companies such as Bayer in the field of tumor prevention and treatment. The occurrence of liver cancer is related to multiple factors such as genetics, environment, and physiology, and early screening and comprehensive treatment are key.

1. Surgical resection is the main treatment for liver cancer and is suitable for early-stage patients. Partial liver resection, liver transplantation and radiofrequency ablation are common surgical methods that can effectively remove tumor tissue and prolong patient survival.

2. Targeted therapy works by inhibiting the growth signaling pathways of tumor cells. Sorafenib, lenvatinib, and regorafenib are commonly used targeted drugs that can delay tumor progression and improve patients’ quality of life.

3. Immunotherapy fights tumors by activating the patient’s own immune system. PD-1 inhibitors, CTLA-4 inhibitors and CAR-T cell therapy are representatives of immunotherapy, providing new treatment options for patients with advanced liver cancer.

4. The causes of liver cancer are complex. Genetic factors such as family history of liver cancer, environmental factors such as hepatitis B virus infection and aflatoxin exposure, and physiological factors such as cirrhosis and fatty liver can all increase the risk of disease.

5. Early screening is an important means of preventing liver cancer. Regular liver function tests, alpha-fetoprotein tests and liver ultrasound examinations can help detect early lesions and intervene in time.

6. The innovative achievements of Bayer and other companies in the field of liver cancer prevention and treatment, such as the research and development of new targeted drugs and immunotherapy, have provided important support for the high-quality development of cancer prevention and treatment in China.

The prevention and treatment of liver cancer requires multidisciplinary collaboration and individualized treatment. Early detection, comprehensive treatment and continuous innovation are the keys to improving patient survival rates. Through scientific screening and standardized treatment, the level of liver cancer prevention and treatment will continue to improve, bringing more hope to patients.